The recent challenges in global distribution have highlighted the necessity of securing critical medications like Ivermectin. Trusting on overseas manufacturers exposes regions to considerable vulnerabilities, including delivery delays, cost fluctuations, and even geopolitical threats. Shifting towards domestic sourcing of Ivermectin offers a multi